Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2022-02-03 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a standard automated regulatory announcement regarding trading mechanics rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the RNS (Regulatory Filings) category.
2022-02-03 English
CE-Mark for self-test for VISITECT® COVID-19 test
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Omega Diagnostics Group PLC regarding the receipt of a CE Mark for their COVID-19 antigen test. It is a standard corporate regulatory announcement detailing operational progress and regulatory status, which does not fit into specific categories like financial reports, shareholder meetings, or director dealings. Therefore, it falls under the RNS (Regulatory Filings) category.
2022-02-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a standard market announcement regarding trading mechanics rather than a financial report, governance document, or corporate action. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory announcement category.
2022-02-02 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Price Monitoring Extension' for a specific security. It does not contain financial results, governance reports, or corporate actions, but rather serves as a standard market regulatory notice. As it does not fit into the specific categories like 10-K, ER, or DVA, it falls under the fallback category for general regulatory announcements.
2022-02-02 English
Speculation regarding a potential fundraise
Regulatory Filings Classification · 1% confidence The document is an RNS announcement from Omega Diagnostics Group PLC regarding potential equity fundraising. It discusses ongoing discussions with investors and shareholders about a capital raise, which directly aligns with the definition of a Capital/Financing Update (CAP). While it is distributed via RNS, the content is specific to financing activities rather than a general regulatory notice or a report publication announcement.
2022-01-31 English
Directorate Change
Board/Management Information Classification · 1% confidence The document is an official announcement from Omega Diagnostics Group PLC regarding the resignation of their CEO and the appointment of a new CEO, as well as the departure of a Non-Executive Director. This falls squarely under the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. While it mentions capital, it is not a primary capital update, and it is not a report publication announcement.
2022-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.